Sella, Aluma Chovel
Becker, Kendra R.
Slattery, Meghan
Hauser, Kristine
Asanza, Elisa
Stern, Casey
Kuhnle, Megan
Micali, Nadia
Eddy, Kamryn T.
Misra, Madhusmita
Thomas, Jennifer J.
Lawson, Elizabeth A.
Article History
Received: 31 January 2023
Accepted: 11 June 2023
First Online: 1 July 2023
Declarations
:
: For participants < 18 years old, written consent was signed by a parent/guardian and assent by the participant. Participants ≥ 18 years signed written consent. All study procedures were approved by the Mass General Brigham Institutional Review Board.
: Not applicable.
: JJT and KTE receive royalties from Cambridge University Press for the sale of their book <i>Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: Children, Adolescents, and Adults</i>. JJT, KRB, and KTE receive royalties from Cambridge University Press for their book <i>The Picky Eater’s Recovery Book: Overcoming Avoidant/Restrictive Food Intake Disorder</i>. EAL has served on the scientific advisory board and has/had a financial interest in OXT Therapeutics, a company that developed oxytocin-based therapeutics to treat obesity and metabolic disease. In addition, EAL received funding for an investigator-initiated study from Tonix Pharmaceuticals. MM has served as a consultant for Abbvie and Sanofi and on the scientific advisory board of Abbvie and Ipsen. Their interests were reviewed and are managed by Massachusetts General Brigham Hospital in accordance with their conflict-of-interest policies. All other co-authors have no conflicts of interest.